Evaluating novel therapies and circulating tumor DNA (ctDNA) as a marker of response in curatively treated gastrointestinal cancers with microscopic residual disease.

被引：1
|
作者：
Mukherji, Reetu
Noel, Marcus Smith
He, Aiwu Ruth
Weinberg, Benjamin Adam
Weiner, Louis M.
Marshall, John
机构：
[1] Georgetown Univ, Ruesch Ctr Cure Gastrointestinal Canc, Lombardi Comprehens Canc Ctr, Washington, DC USA
[2] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 3_SUPPL期
关键词：
3282-415-6705; 613-545-552; 130-540-543; 261-492-11294; 261-492-341; 283-237-255; 261-492-3532-2370; 17; 6; 4; 3; 2; 3604;
D O I：
10.1200/JCO.2024.42.3_suppl.TPS765
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：TPS765 / TPS765
页数：1
相关论文
共 50 条
  • [21] Circulating tumor cells as a biomarker for monitoring: Disease progression, treatment response, and minimal residual disease.
    Raut, Nirmal Vivek
    Bharde, Atul
    Gourishankar, Aland
    Jayant, Sreeja
    Garbhe, Meghana
    Gosavi, Sayali
    Janorkar, Apoorva
    D'Souza, Alain
    Vasudevan, Aravindan
    Khandare, Jayant
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [22] Circulating tumor DNA (ctDNA) for response assessment in patients with anal cancer treated with definitive chemoradiation.
    Alvarez, Janet
    Cercek, Andrea
    Mohan, Natasha
    Cuaron, John J.
    Zinovoy, Melissa
    Reyngold, Marsha
    Yaeger, Rona
    Hajj, Carla
    Fanta, Corrine
    Wong, Charles
    Segal, Neil Howard
    Paty, Philip
    Crane, Christopher H.
    Garcia-Aguilar, Julio
    Weiser, Martin R.
    Smith, Jesse Joshua
    Tuli, Richard
    Romesser, Paul Bernard
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 1 - 1
  • [23] Circulating tumor DNA as a marker of recurrence risk in locoregional esophagogastric cancers with pathologic complete response
    Lander, Eric Michael
    Huffman, Brandon
    Klempner, Samuel J.
    Aushev, Vasily N.
    Ferguson, Jenifer
    Sharma, Shruti
    Jurdi, Adham A.
    Liu, Minetta C.
    Eng, Cathy
    Gibson, Michael K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [24] Enhanced detection of molecular residual disease (MRD) by tumor-informed and tumor-agnostic variants in circulating tumor DNA (ctDNA)
    Yan, Xiaoluan
    Li, Zhencong
    Wang, YanYan
    Li, Juan
    Liu, Ming
    Wang, Hongwei
    Jin, Kemin
    Bao, Quan
    Wang, Lijun
    Liu, Wei
    Liu, Lijuan
    Da, Xu
    Hu, Yifan
    Zhang, Yiqun
    Zang, Yuehua
    Pei, Zhihua
    Wang, Dongliang
    Zhou, Qiming
    Xing, Baocai
    Wang, Kun
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [25] Development of Circulating Tumor DNA (ctDNA) for Molecular Measurable Residual Disease (MRD) in Acute Myeloid Leukemia (AML)
    Gunaratne, Ruwan
    Zhou, Crystal
    Tai, Jesse W.
    Schwede, Matthew
    Tanaka, Kailee
    Alkaitis, Matthew
    Yin, Raymond
    Sworder, Brian J.
    Mannis, Gabriel
    Majeti, Ravindra
    Khodadoust, Michael S.
    Kurtz, David M.
    Zhang, Tian Y.
    BLOOD, 2023, 142
  • [26] The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA
    Liu, Binliang
    Hu, Zheyu
    Ran, Jialu
    Xie, Ning
    Tian, Can
    Tang, Yu
    Ouyang, Quchang
    BREAST, 2022, 65 : 116 - 123
  • [27] Circulating tumor DNA as a marker of recurrence risk in locoregional esophagogastric cancers with pathologic complete response.
    Lander, Eric Michael
    Huffman, Brandon
    Klempner, Samuel J.
    Aushev, Vasily N.
    Carbonell, Jesus Izaguirre
    Ferguson, Jenifer
    Sharma, Shruti
    Jurdi, Adham A.
    Liu, Minetta C.
    Eng, Cathy
    Gibson, Michael K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 : 452 - 452
  • [28] Longitudinal evaluation of circulating tumor DNA (ctDNA) as a prognostic biomarker to detect minimal residual disease (MRD) in testicular cancer
    Hassoun, Rebecca
    Ben-David, Reuben
    Sfakianos, John P.
    Laliotis, George
    Cary, Clint
    Masterson, Timothy A.
    Rivero-Hinojosa, Samuel
    Manage, Kevin
    Dutta, Punashi
    Tillu, Neeraja
    Cumarasamy, Shivaram
    King, Jennifer
    Rich, Jordan
    Rock, Adam
    Dorff, Tanya B.
    ElNaggar, Adam
    Liu, Minetta C.
    Einhorn, Lawrence H.
    Chehrazi-Raffle, Alex
    Adra, Nabil
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] Circulating Tumor DNA as a Marker of Minimal Residual Disease After Radical Resection of Colorectal Liver Metastases
    Marmorino, Federica
    Prisciandaro, Michele
    Giordano, Mirella
    Ortolan, Elisa
    Crucitta, Stefania
    Manca, Paolo
    Antoniotti, Carlotta
    Valenti, Marta Maria
    Danesi, Romano
    Conca, Veronica
    Mazzoli, Giacomo
    Boccaccino, Alessandra
    Carullo, Martina
    Martinetti, Antonia
    Sottotetti, Elisa
    Masi, Gianluca
    Sposito, Carlo
    Zaffaroni, Nadia
    Milione, Massimo
    Fontanini, Gabriella
    Del Re, Marzia
    Pietrantonio, Filippo
    Cremolini, Chiara
    JCO PRECISION ONCOLOGY, 2022, 6
  • [30] Circulating Tumor DNA as a Potential Marker to Detect Minimal Residual Disease and Predict Recurrence in Pancreatic Cancer
    Jiang, Jiahong
    Ye, Song
    Xu, Yaping
    Chang, Lianpeng
    Hu, Xiaoge
    Ru, Guoqing
    Guo, Yang
    Yi, Xin
    Yang, Liu
    Huang, Dongsheng
    FRONTIERS IN ONCOLOGY, 2020, 10
12345